NCT02502825View on ClinicalTrials.gov

Comparison of Methacholine Bronchial Provocation With Wright and Devilbiss646 Nebulizers

NACompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

July 31, 2016

Study Completion Date

December 31, 2016

Conditions
Asthma
Interventions
OTHER

methacholine

methacholine (0.03,0.06,0.125,0.5,1.0,2.0,4.0,8.0,16.0 mg/ml),Canada

DEVICE

Wright Nebulizer

nebulized for 2 minutes with an output of 0.13ml/min

DEVICE

Devilbiss646 Nebulizer

nebulized for 2 minutes with an output of 0.13ml/min

Trial Locations (1)

510120

Guangzhou institute of respiratory disease, Guangzhou

All Listed Sponsors
collaborator

Firestone Institute for Respiratory Health

OTHER

lead

Guangzhou Institute of Respiratory Disease

OTHER

NCT02502825 - Comparison of Methacholine Bronchial Provocation With Wright and Devilbiss646 Nebulizers | Biotech Hunter | Biotech Hunter